Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fish for fatigue? study tests Omega-3 diet for breast cancer survivors

NCT ID NCT04293874

Completed Knowledge-focused Sponsor: University of Connecticut Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether a personalized meal plan with more omega-3 fatty acids (found in fish) could reduce fatigue, pain, depression, sleep problems, and stress in women who finished treatment for early-stage breast cancer 1-2 years earlier. Researchers enrolled 98 women and measured symptoms and inflammation markers before and after the 10-week diet plan. The main goal was to see if this type of study is feasible, not to prove the diet works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Personalized meal plan (behavioral intervention)
What this could lead to
If successful, this could point toward a simple, cost-effective dietary strategy to help breast cancer survivors manage common lingering symptoms like fatigue and pain.
What could go wrong
This is a small, early feasibility study with only 98 participants. It cannot prove the diet works—it only tests whether such a study can be done. Results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Depression depressive disorder Fatigue Feeding Behavior Pain Parasomnias sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER DEPRESSION DIETARY HABITS FATIGUE PAIN SLEEP DISTURBANCE STRESS SURVIVORSHIP

Contacts and locations

Locations

  • Hartford HealthCare Cancer Institue

    Hartford, Connecticut, 06102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.